VIDA Completes Second Close Of Round C Financing
CORALVILLE, Iowa, April 15, 2020 -- (Healthcare Sales & Marketing Network) -- VIDA Diagnostics, Inc. ("VIDA"), the leader in AI-powered lung imaging analysis, received $2M from OSF Ventures, the corporate investment arm of OSF HealthCare, as a s... Devices, Venture Capital VIDA Diagnostics, COPD, asthma, interstitial lung disease, lung cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Asthma | Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | Interstitial Lung Disease | Lung Cancer | Marketing | Pharmaceuticals | Venture Capital